SCHEMBL7385335

SCHEMBL7385335

OCc1ccccc1SCCCCCl

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
APOBEC3G Q9HC16 1/20 0.52
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
PKM P14618 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
PTGS2 P35354 9/20 0.36
SLC6A4 P31645 2/20 0.35
EPHX2 P34913 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
LDHA P00338 1/20 0.31
CYSLTR2 Q9NS75 1/20 0.31
CYSLTR1 Q9Y271 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10367304 0.95 APOBEC3G (0.53) APOBEC3GNPC1LMNAPKMHTT
SCHEMBL10365374 0.87 APOBEC3G (0.57) APOBEC3GPTGS2SLC6A4CYP1A2CYP2D6
SCHEMBL9428059 0.81 APOBEC3G (0.50) APOBEC3GPTGS2CYP1A2CYP2D6CYP2C19
SCHEMBL9727526 0.80 APOBEC3G (0.53) APOBEC3GNPC1LMNAHTTRAB9A
SCHEMBL28840959 0.74 RAB9A (0.40) NPC1LMNAPKMHTTRAB9A
SCHEMBL9429059 0.74 APOBEC3G (0.39) APOBEC3GPTGS2
SCHEMBL7362224 0.71 APOBEC3G (0.61) APOBEC3GLMNAHTTSLC6A4CYP1A2
SCHEMBL7384646 0.70 LMNA (0.40) NPC1LMNAPKMHTTRAB9A
SCHEMBL9633956 0.70 APOBEC3G (0.67) APOBEC3GLMNASLC6A4LDHA
SCHEMBL1903485 0.69 APOBEC3G (0.59) APOBEC3GLMNAHTTCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5314887-A Cardiovascular disorders THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-05-24 US disclosed
US-5166148-A Treatment of congestive heart failure THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-11-24 US disclosed
WO-1992000741-A1 2-AMINO-1,4-DIHYDROPYRIDINE DERIVATIVES WITH CALCIUM AGONIST AND ALPHA1-ANTAGONIST ACTIVITY THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-01-23 WO disclosed